Beijing Sun-Novo Pharmaceutical Research Co Ltd

SSE:688621

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beijing Sun-Novo Pharmaceutical Research Co Ltd's stock price target?

Price Target

75.04 CNY

According to Wall Street analysts, the average 1-year price target for Beijing Sun-Novo Pharmaceutical Research Co Ltd is 75.04 CNY .

What is Beijing Sun-Novo Pharmaceutical Research Co Ltd's Revenue forecast?

Projected CAGR

35%

For the last 3 years the compound annual growth rate for Beijing Sun-Novo Pharmaceutical Research Co Ltd's revenue is 43%. The projected CAGR for the next 3 years is 35%.

What is Beijing Sun-Novo Pharmaceutical Research Co Ltd's Operating Income forecast?

Projected CAGR

37%

For the last 3 years the compound annual growth rate for Beijing Sun-Novo Pharmaceutical Research Co Ltd's operating income is 46%. The projected CAGR for the next 3 years is 37%.

What is Beijing Sun-Novo Pharmaceutical Research Co Ltd's Net Income forecast?

Projected CAGR

38%

For the last 3 years the compound annual growth rate for Beijing Sun-Novo Pharmaceutical Research Co Ltd's net income is 49%. The projected CAGR for the next 3 years is 38%.